| 标题 |
Ph I/II study of oral selective AXL inhibitor bemcentinib (BGB324) in combination with erlotinib in patients with advanced EGFRm NSCLC: End of trial update |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:Lauren Averett Byers; Kathryn A. Gold; Julio Antonio Peguero; Melissa Lynne Johnson; Jorge J. Nieva; et al 出版日期:2021 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)